Abstract
Goals of work
The National Cancer Institute’s Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium is conducting a population-based study of newly diagnosed patients with lung and colorectal cancer to describe the experience of persons living with cancer and to understand which barriers present the most significant obstacles to their receipt of appropriate care. The keystone to this effort is the baseline patient survey administered approximately 4 months after diagnosis.
Patients and methods
We developed a survey to obtain information from patients newly diagnosed with lung and colorectal cancer about their personal characteristics, decision making, experience of care, and outcomes. We conducted a pilot study to evaluate the feasibility of a lengthy and clinically detailed interview in a convenience sample of patients within 8 months of diagnosis (n=71).
Main results
The median length of the interviews was 75 min for patients with lung cancer (range 43–130) and 82 min for patients with colorectal cancer (range 46–119). Most patients had received some form of treatment for their cancer: 66.1% had undergone surgery, 28.2% had received radiation therapy, and 54.9% were treated with chemotherapy. In addition, 26.7% reported their overall health was less than 70 on a 0–100 scale, demonstrating that patients with substantial health impairment were able to complete the survey.
Conclusions
A clinically detailed survey of newly diagnosed lung and colorectal cancer patients is feasible. A modified version of this survey is being fielded by the CanCORS Consortium and should provide much needed population-based data regarding patients’ experiences across the continuum of cancer care and their outcomes.
Similar content being viewed by others
References
Cancer survivorship—United States, 1971–2001 (2004) MMWR Morb Mortal Wkly Rep 53:526–529
Cella DF, Bonomi AE (1995) Measuring quality of life: 1995 update. Oncology (Huntingt) 9:47–60
Ganz PA (2002) What outcomes matter to patients: a physician-researcher point of view. Med Care 40:III11–III19
Ganz PA (1994) Quality of life and the patient with cancer. Individual and policy implications. Cancer 74:1445–1452
Aaronson NK (1988) Quality of life: what is it? How should it be measured? Oncology (Huntingt) 2:69–76
Hewitt M, Rowland JH, Yancik R (2003) Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci 58:82–91
Rowland JH, Aziz N, Tesauro G et al (2001) The changing face of cancer survivorship. Semin Oncol Nurs 17:236–240
Lipscomb J, Donaldson MS (2003) Outcomes research at the National Cancer Institute: measuring, understanding, and improving the outcomes of cancer care. Clin Ther 25:699–712
Brown ML, Lipscomb J, Snyder C (2001) The burden of illness of cancer: economic cost and quality of life. Annu Rev Public Health 22:91–113
Freeman HP, Reuben SH (eds) (2002) Voices of a broken system: real people, real problems. President’s Cancer Panel, Report of the Chairman, 2000–2001. National Cancer Institute, National Institutes of Health, Bethesda, MD
Reuben SH (2004) Living beyond cancer: finding a new balance. President’s Cancer Panel, 2003–2004 Annual Report. National Cancer Institute, National Institutes of Health, Bethesda, MD
Hewitt M, Simone J (eds) (1999) Ensuring quality cancer care. National Cancer Policy Board, Institute of Medicine, National Academy Press, Washington, DC, pp i–236
Yabroff KR, Lawrence WF, Clauser S et al (2004) Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst 96:1322–1330
Shavers VL, Brown ML (2002) Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 94:334–357
Potosky AL, Harlan LC, Kaplan RS et al (2002) Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol 20:1192–1202
Potosky AL, Saxman S, Wallace RB et al (2004) Population variations in the initial treatment of non-small-cell lung cancer. J Clin Oncol 22:3261–3268
Bach PB, Cramer LD, Warren JL et al (1999) Racial differences in the treatment of early-stage lung cancer. N Engl J Med 341:1198–1205
Schrag D, Cramer LD, Bach PB et al (2001) Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 93:850–857
Hodgson DC, Fuchs CS, Ayanian JZ (2001) Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer. J Natl Cancer Inst 93:501–515
Ayanian JZ, Zaslavsky AM, Fuchs CS et al (2003) Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol 21:1293–1300
Hillner BE, McDonald MK, Desch CE et al (1998) A comparison of patterns of care of nonsmall cell lung carcinoma patients in a younger and Medigap commercially insured cohort. Cancer 83:1930–1937
de Rijke JM, Schouten LJ, Schouten HC et al (1996) Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, The Netherlands [see comments]. Ann Oncol 7:677–685
Fry WA, Menck HR, Winchester DP (1996) The National Cancer Data Base report on lung cancer. Cancer 77:1947–1955
Earle CC, Venditti LN, Neumann PJ et al (2000) Who gets chemotherapy for metastatic lung cancer? Chest 117:1239–1246
Lackan NA, Ostir GV, Freeman JL et al (2004) Decreasing variation in the use of hospice among older adults with breast, colorectal, lung, and prostate cancer. Med Care 42:116–122
Ayanian JZ, Chrischilles EA, Wallace RB et al (2004) Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol 22:2992–2996
National Cancer Institute: The Nation’s Investment in Cancer Research (2002) NIH Publication No. 03-4373. Bethesda, MD
Ganz PA, Haskell CM, Figlin RA et al (1988) Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index-Cancer. Cancer 61:849–856
Finkelstein DM, Cassileth BR, Bonomi PD, Ruckdeschel JC, Ezdinli EZ, Wolter JM (1988) A pilot study of the Functional Living Index-Cancer (FLIC) scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study. Am J Clin Oncol 11:630–633
Frey JH (1989) Survey research by telephone, 2nd edn. In: SAGE Libr Soc Res, vol 150. Sage, Beverly Hills, CA, pp 33–78
Ketola E, Klockars M (1999) Computer-assisted telephone interview (CATI) in primary care. Fam Pract 6:179–183
California Health Interview Survey (2001) UCLA Center for Health Policy Research
Ponce NA, Lavarreda SA, LS, Yen W, Brown ER, DiSogra C, Satter DE (2004) The California Health Interview Survey 2001: translation of a major survey for California’s multiethnic population. Public Health Rep 119:388–395
Bradley CJ Labor market outcomes of long-term cancer survivors, R01 CA86045-01A1. National Cancer Institute
Tao ML, Malin J, Ganz P et al (2004) Predictors of use of sentinel lymph node biopsy (SNB) in a population-based cohort of breast cancer (BC) patients (pts). J Clin Oncol, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition) 22:6006
Comis RL, Miller JD, Aldige CR, Krebs L, Stoval E (2003) Public attitudes toward participation in cancer clinical trials. J Clin Oncol 21:830–835
Ware J Jr, Kosinski M, Keller SD (1996) A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220–233
Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376
Sprangers MA, te Velde A, Aaronson NK (1999) The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Eur J Cancer 35:238–247
Aaronson NK, Cull A, Kaasa S et al (1994) The European Organization for Research and Treatment of Cancer (EORTC) modular approach to quality of life assessment in oncology. Int J Ment Health 23:75–96
Huba GJ, Melchior LA (1995) Staff of The Measurement Group, and HRSA/HAB’s SPNS Cooperative Agreement Steering Committee: Module 26B: CES-D8 Form (Interview). http://www.themeasurementgroup.com/modules/ins_mod26b.htm. Last accessed 10 September 2004
Melchior LA, Huba GJ, Brown VB, Reback CJ (1993) A short depression index for women. Educ Psychol Meas 53:1117–1125
Cleeland C (1991) Brief Pain Inventory Short Form. http://www.mdanderson.org/pdf/bpisf.pdf. Last accessed 9 September 2004
Cleeland CS RK (1994) Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 23:129–138
Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483
Ware JE Jr, Kosinski M, Bayliss MS et al (1995) Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 33:AS264–AS279
Katz JN, Chang LC, Sangha O et al (1996) Can comorbidity be measured by questionnaire rather than medical record review? Med Care 34:73–84
Klabunde CN, Reeve BB, Harlan LC et al (2005) Do patients consistently report comorbid conditions over time? Results from the Prostate Cancer Outcomes Study. Med Care 43:391–400
Hedley AA, Ogden CL, Johnson CL et al (2004) Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA 291:2847–2850
Wagenknecht LE, Burke GL, Perkins LL et al (1992) Misclassification of smoking status in the CARDIA study: a comparison of self-report with serum cotinine levels. Am J Public Health 82:33–36
National Cancer Institute Diet History Questionnaire, Version 1.0. Available at http://riskfactor.cancer.gov/DHQ/forms/. Last accessed 21 August 2005
Brooks R, Rabin RE, de Charro FE (eds) (2003) The measurement and valuation of health status using EQ-5D: a European perspective. Kluwer, Rotterdam, The Netherlands
Hays RD, Shaul JA, Williams VS et al (1999) Psychometric properties of the CAHPS 1.0 survey measures. Consumer Assessment of Health Plans Study. Med Care 37:MS22–MS31
Cleary PD, Edgman-Levitan S, Roberts M et al (1991) Patients evaluate their hospital care: a national survey. Health Aff (Millwood) 10:254–267
Ayanian JZ, Zaslavsky AM, Guadagnoli E et al (2005) Patients’ perceptions of quality of care for colorectal cancer by race, ethnicity, and language. J Clin Oncol 23:6576–6586
Degner LF, Kristjanson KL, Bowman D, Sloan JA, Carriere KC, O’Neil J, Bilodeau B WP, Mueller B (1997) Information needs and decisional preferences in women with breast cancer. JAMA 277:1485–1492
Degner LF, Sloan JA, Venkatesh P (1997) The Control Preferences Scale. Can J Nurs Res 29:21–43
McLaughlin GH (1969) SMOG grading—a new readability formula. J Read 12:639–636
Fry E (1977) Fry’s readability graph: clarifications, validity, and extension to level 17. J Read 21:242–252
Morales LS, Weidmer BO, Hays RD (2001) Readability of CAHPS 2.0 Child and Adult Core Surveys. In: Cynamon ML, Kulka RA (eds) Proceedings of the seventh conference on health survey research methods. Department of Health and Human Services, Hyattsville, MD, pp 83–90
Aaronson N (1989) Quality of life assessment in clinical trials: methodologic issues. Control Clin Trials 10:195S–208S
Fromme EK, Eilers KM, Mori M et al (2004) How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the quality-of-life questionnaire C30. J Clin Oncol 22:3485–3490
Acknowledgements
We thank Marci Campbell, Virginia Casey, Elizabeth Chrischilles, Craig Earle, Mona Fouad, Nancy Keating, Josh Klapow, Carrie Klabunde, Joseph Lipscomb, Arnold Potosky, Robert Sandler, Joan Teno, Jane Weeks, and Dee West for their thoughtful suggestions; Ronald Hays, Jack Fowler, and Gordon Willis for reviewing an initial draft of the patient survey; and Gary Ansell, Susan Baum, Diana Evensen, Judy Goldstein, Susan Jackson, Barbara Kahn, and Erin Sedars for recruiting patients for the pilot study and helpful feedback on the survey design. This study is supported by grants from the National Cancer Institute (U01 CA93324, U01 CA93326, U01 CA93329, U01 CA93332, U01 CA93339, U01 CA93344, and U01 CA93348) and from the Department of Veterans Affairs (CRS 02-164). Dr. Malin received funding from a CI-10 Damon Runyon-Lilly Clinical Investigator Award from the Damon Runyon Cancer Research Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Malin, J.L., Ko, C., Ayanian, J.Z. et al. Understanding cancer patients’ experience and outcomes: development and pilot study of the Cancer Care Outcomes Research and Surveillance patient survey. Support Care Cancer 14, 837–848 (2006). https://doi.org/10.1007/s00520-005-0902-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-005-0902-8